---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-042308"
form_type: "8-K"
ticker: "SGMO"
cik: "0001001233"
company_name: "SANGAMO THERAPEUTICS, INC"
filed_at: "2024-10-04T23:59:59+00:00"
generated_at: "2026-05-30T19:44:54.897905+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sangamo files to validate share increase; stockholder challenge; hearing Dec 12

## Summary
- Stockholder lawsuit claims wrong voting standard for share increase; company seeks validation.
- Sangamo filed Section 205 petition to validate amendment increasing authorized shares from 640M to 960M.
- Vote results: 107.95M for (52% of outstanding, 92% of votes cast); both standards met.
- Court of Chancery hearing scheduled Dec 12, 2024; opposition due Nov 12.
- Company previously warned of going concern risk; validation needed to enable equity fundraising.

## SEC filing metadata
- accession: 0001628280-24-042308
- form_type: 8-K
- ticker: SGMO
- cik: 0001001233
- company_name: SANGAMO THERAPEUTICS, INC
- filed_at: 2024-10-04T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001233/000162828024042308/0001628280-24-042308-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001233/000162828024042308/sgmo-20241004.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-042308
- JSON: https://secwatch.observer/filing/0001628280-24-042308.json
- Plain text: https://secwatch.observer/filing/0001628280-24-042308.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.